Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$83.14 - $145.99 $12 Million - $21.1 Million
-144,476 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$110.08 - $142.92 $12.6 Million - $16.3 Million
-114,021 Reduced 44.11%
144,476 $17.1 Million
Q4 2021

Feb 14, 2022

BUY
$99.73 - $148.48 $834,839 - $1.24 Million
8,371 Added 3.35%
258,497 $35.6 Million
Q3 2021

Nov 15, 2021

SELL
$98.85 - $138.91 $11,071 - $15,557
-112 Reduced 0.04%
250,126 $34.7 Million
Q2 2021

Aug 16, 2021

SELL
$65.78 - $105.02 $867,111 - $1.38 Million
-13,182 Reduced 5.0%
250,238 $24.3 Million
Q1 2021

May 17, 2021

BUY
$64.07 - $91.75 $10.4 Million - $14.9 Million
162,113 Added 160.02%
263,420 $18 Million
Q4 2020

Feb 16, 2021

SELL
$65.07 - $98.24 $30,192 - $45,583
-464 Reduced 0.46%
101,307 $8.68 Million
Q3 2020

Nov 16, 2020

SELL
$59.04 - $77.95 $34,302 - $45,288
-581 Reduced 0.57%
101,771 $6.62 Million
Q2 2020

Aug 14, 2020

BUY
$29.01 - $74.23 $5,598 - $14,326
193 Added 0.19%
102,352 $7.48 Million
Q1 2020

May 15, 2020

BUY
$27.51 - $57.29 $2.81 Million - $5.85 Million
102,159 New
102,159 $3.48 Million
Q4 2017

Jan 31, 2018

SELL
$20.44 - $35.56 $1.53 Million - $2.65 Million
-74,637 Closed
0 $0
Q3 2017

Nov 06, 2017

BUY
$23.54 - $38.21 $1.76 Million - $2.85 Million
74,637
74,637 $2.79 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.